Pharmaceutical compositions of ghrh analogs and uses thereof
CA3037757A1
Pharmaceutical compositions of ghrh analogs and uses thereof
US2014249083A1
Formulations of growth hormone releasing factor (GRF) molecules with improved stability
US2015133385A1
Peptide compounds derived from melanotransferrin and uses thereof
KR20140027284A
Growth hormone releasing factor (grf) analogs and uses thereof
WO2012094755A1
Assessment of igf-1 levels in hiv-infected subjects and uses thereof
WO2010121352A1
Use of (hexenoyl trans-3)hgrf(l-44)nh2 and simvastatin in combination therapy
WO2010121351A1
Use of (hexenoyl trans-3)hgrf(1-44)nh2 and ritonavir in combination therapy
AU2008274845A1
Bifunctional fusion proteins of the alpha-melanocyte stimulating hormone (alpha-MSH) and atrial natriuretic protein (ANP) and uses in hypertension and acute kidney injury
AU2008235215A1
Pharmaceutical formulations of GHRH molecules
KR20070069207A
Gh secretagogues and uses thereof
WO2005080412A1
Modulators of fatty acid-stimulated insulin secretion and uses thereof
WO2005080413A1
Modulators of blood glucose levels and uses thereof
CN1910201A
Glucagon-like peptide-1 analogs with long duration of action
BRPI0506694A
Long-acting glucagon-like peptide-1 analogs
WO2005039624A1
Use of ghrelin and unacylated ghrelin compostions in insulin-related disease conditions
CA2542433A1
Use of growth hormone releasing factor analogs in treating patients suffering from wasting
CA2485472A1
Gh secretagogues and uses thereof
US2005164949A1
Antagonistic peptides of prostaglandin E2 receptor subtype EP4
WO2004067548A2
Chemically modified metabolites of regulatory peptides and methods of producing and using same
